Selection and Evaluation of a Silver Nanoparticle Imaging Agent for Dual-Energy Mammography

Over the past decade, contrast-enhanced (CE) dual-energy (DE) x-ray breast imaging has emerged as an exciting, new modality to provide high quality anatomic and functional information of the breast. The combination of these data in a single imaging procedure represents a powerful tool for the detection and diagnosis of breast cancer. The most widely used implementation of CEDE imaging is k-edge imaging, whereby two x-ray spectra are placed on either side of the k-edge of the contrast material. Currently, CEDE imaging is performed with iodinated contrast agents. The lower energies used in clinical DE breast imaging systems compared to imaging systems for other organs suggest that an alternative material may be better suited. We developed an analytical model to compare the contrast of various elements in the periodic table. The model predicts that materials with atomic numbers from 42 to 52 should provide the best contrast in DE breast imaging while still providing high-quality anatomical images. Upon consideration, silver was chosen for more detailed study. Through simulation and experimental validation, we determined that not only does silver perform better than iodine when imaged at their respective optimal conditions, but silver is able to provide higher levels of contrast than iodine when imaged with current protocols that are optimal for iodine. Therefore, a silver agent could be translated to the clinic without modification of existing imaging systems or techniques. A prototype silver agent was designed. The agent consists of (i) a silver core for DE contrast, (ii) a silica shell to prevent the release of toxic silver cations, and (iii) a polyethylene glycol layer to improve the biocompatibility of the entire nanostructure. DE imaging with the particles showed a 9-fold increase in contrast when injected into mice, while displaying no acutely toxic effects. The prototype silica-silver nanoparticles represent a first step in developing a biologically stable contrast agent that is specifically suited for DE breast imaging

Imaging of the Breast

Early detection of breast cancer combined with targeted therapy offers the best outcome for breast cancer patients. This volume deal with a wide range of new technical innovations for improving breast cancer detection, diagnosis and therapy. There is a special focus on improvements in mammographic image quality, image analysis, magnetic resonance imaging of the breast and molecular imaging. A chapter on targeted therapy explores the option of less radical postoperative therapy for women with early, screen-detected breast cancers

Evaluation of a diffraction-enhanced imaging (DEI) prototype and exploration of novel applications for clinical implementation of DEI

Conventional mammographic image contrast is derived from x-ray absorption, resulting in breast structure visualization due to density gradients that attenuate radiation without distinction between transmitted, scattered, or refracted x-rays. Diffraction-enhanced imaging (DEI) allows for increased contrast with decreased radiation dose compared to conventional mammographic imaging due to monochromatic x-rays, its unique refraction-based contrast mechanism, and excellent scatter rejection. Although laboratory breast imaging studies have demonstrated excellent breast imaging, important clinical translation and application studies are needed before the DEI system can be established as a useful breast imaging modality. This dissertation focuses on several important studies toward the development of a clinical DEI system. First, contrast-enhanced DEI was explored using commercially available contrast agents. Phantoms were imaged at a range of x-ray energies and relevant contrast agent concentrations. Second, we performed a reader study to determine if superior DEI contrast mechanisms preserve image quality as tissue thickness increases. Breast specimens were imaged at several thicknesses, and radiologist perception of lesion visibility was recorded. Lastly, a prototype DEI system utilizing an x-ray tube source was evaluated through a reader study. Breast tissue specimens were imaged on the traditional and prototype DEI systems, and expert radiologists evaluated image quality and pathology correlation. This dissertation will demonstrate proof-of-principle for contrast-enhanced DEI, establishing the feasibility of contrast-enhanced DEI using commercially available contrast agents. Further, it will show that DEI might be able to reduce breast compression, and thus the perception of pain during mammography, without significantly decreasing breast lesion visibility. Finally, this research shows the successful implementation of a DEI prototype, displaying breast features with approximately statistically equivalent visibility to the traditional DEI system. Together, this research is an important step toward the clinical translation of DEI, a technology with the potential to facilitate early breast cancer detection and diagnosis

Diseases of the Chest, Breast, Heart and Vessels 2019-2022

This open access book focuses on diagnostic and interventional imaging of the chest, breast, heart, and vessels. It consists of a remarkable collection of contributions authored by internationally respected experts, featuring the most recent diagnostic developments and technological advances with a highly didactical approach. The chapters are disease-oriented and cover all the relevant imaging modalities, including standard radiography, CT, nuclear medicine with PET, ultrasound and magnetic resonance imaging, as well as imaging-guided interventions. As such, it presents a comprehensive review of current knowledge on imaging of the heart and chest, as well as thoracic interventions and a selection of "hot topics". The book is intended for radiologists, however, it is also of interest to clinicians in oncology, cardiology, and pulmonology

Diseases of the Chest, Breast, Heart and Vessels 2019-2022

This open access book focuses on diagnostic and interventional imaging of the chest, breast, heart, and vessels. It consists of a remarkable collection of contributions authored by internationally respected experts, featuring the most recent diagnostic developments and technological advances with a highly didactical approach. The chapters are disease-oriented and cover all the relevant imaging modalities, including standard radiography, CT, nuclear medicine with PET, ultrasound and magnetic resonance imaging, as well as imaging-guided interventions. As such, it presents a comprehensive review of current knowledge on imaging of the heart and chest, as well as thoracic interventions and a selection of "hot topics". The book is intended for radiologists, however, it is also of interest to clinicians in oncology, cardiology, and pulmonology

Endorectal Digital Prostate Tomosynthesis

Several areas of prostate cancer (PCa) management, such as imaging permanent brachytherapy implants or small, aggressive lesions, benefit from high image resolution. Current PCa imaging methods can have inadequate resolution for imaging these areas. Endorectal digital prostate tomosynthesis (endoDPT), an imaging method that combines an external x-ray source and an endorectal x-ray sensor, can produce three-dimensional images of the prostate region that have high image resolution compared to typical methods. This high resolution may improve PCa management and increase positive outcomes in affected men. This dissertation presents the initial development of endoDPT, including system design, image quality assessment, and examples of possible applications to prostate imaging. Experiments using computational phantoms, physical phantoms, and canine prostate specimens were conducted. Initial system design was performed computationally and three methods of endoDPT image reconstruction were developed: shift and add (SAA), backprojection (BP), and filtered BP (FBP). A physical system was developed using an XDR intraoral x-ray sensor and a GE radiography unit. The resolution and radiation dose of endoDPT were measured and compared to a GE CT scanner. Canine prostate specimens that approximated clinical cases of PCa management were imaged and compared using endoDPT, the above CT scanner, and a GE MRI scanner. This study found that the resolution of endoDPT was significantly higher than CT. The radiation dose of endoDPT was significantly lower than CT in the regions of the phantom that were not in the endoDPT field of view (FoV). Inside the endoDPT FoV, the radiation dose ranged from significantly less than to significantly greater than CT. The endoDPT images of the canine prostate specimens demonstrated qualitative improvements in resolution compared to CT and MRI, but endoDPT had difficulty in visualizing larger structures, such as the prostate border. Overall, this study has demonstrated endoDPT has high image resolution compared to typical methods of PCa imaging. Future work will be focused on development of a prototype system that improves scanning efficiency that can be used to optimize endoDPT and perform pre-clinical studies

Exploring Novel Contrast Agents with Anthropomorphic Mesh Models in MCNP

Breast cancer is the leading cancer in women with an estimated 13% of women in the United States developing a form of invasive breast cancer in her lifetime. The survival rate is estimated to be 85%, but the American Cancer Society estimates that early detection of breast cancer in the localized stage increases the breast cancer survival rate to 99%. However, early detection is dependent on the sensitivity of breast imaging techniques and currently, the sensitivity is suboptimal for women with dense breasts and obscure cancers. Recently, studies have indicated that exploring new contrast agents can provide access to improved sensitivity because of their potential to increase the effective Z of the target tissue. Furthermore, contrast-enhanced tomosynthesis is a viable imaging method that can provide a 3D view of the breast while providing tumor enhancement for improved visibility. This project aims to facilitate the search for practical contrast agents that can improve sensitivity during breast imaging. More specifically, the objective of this project is to find novel ways to improve the differentiation between tumor and glandular tissue by creating a realistic anthropomorphic model that not only considers the geometry of the breast but its physiological components as well. This project aims to combine tomosynthesis breast imaging methods with novel contrast agents to explore their efficacy and limitations. To achieve the goals of this project, several techniques are employed. A realistic tomosynthesis environment is created by constructing a detailed Hologic tomosynthesis breast imaging machine, including the source, flat-panel detector, and support equipment, using MCNP. Realistic breast phantoms that consider geometric and biophysical accuracy are created by incorporating a time dependency into the model. Once the contrast agents are incorporated, their efficacy is calculated by quantifying tumor visibility as a function of breast size, density, tumor location, tumor stage, and tumor type. After running simulations, this project will generate clear and accurate radiographs demonstrating the structural components of the breast and the effects of contrast enhancement on any embedded tumors. The results will provide an indication of the contrast agents that provide promise. The data acquired in this project will provide insight on the process of creating an anthropomorphic breast phantom for tomosynthesis studies, as well as insight on setbacks that are identified with the methods used. Contrast-enhanced tomosynthesis is clinically possible and is a promising technique for improving sensitivity. This project explores this technique and provides insight on possible ways to improve breast imaging sensitivity

Focal Spot, Summer 1994

https://digitalcommons.wustl.edu/focal_spot_archives/1067/thumbnail.jp

Development of a Stationary Digital Breast Tomosynthesis System for Clinical Applications

Digital breast tomosynthesis (DBT) has been shown to be a very beneficial tool in the fight against breast cancer. However, current DBT systems have poor spatial resolution compared to full field digital mammography (FFDM), the current gold standard for screening mammography. The poor spatial resolution of DBT systems is a result of the single X-ray source design. In DBT systems a single X-ray source is rotated over an angular span in order to acquire the images needed for 3D reconstruction. The rotation of the X-ray source degrades the spatial resolution of the images. DBT systems which are approved for use in the United States for screening mammography are required to also take a full field digital mammogram with every DBT acquisition in order to compensate for the poor spatial resolution. This double exposure essentially doubles the radiation dose to patients. Over the past few years our research group has developed a carbon nanotube (CNT) based X-ray source technology. The unique nature of CNT X-ray sources allows for multiple X-ray focal spots in a single X-ray source. Using this technology we have recently developed a stationary DBT system (s-DBT) system which is capable of producing a full tomosynthesis image dataset with zero motion of the X-ray source. This system has been shown to have increased spatial resolution over other DBT systems in a laboratory setting. The goal of this thesis work was to optimize the s-DBT system, demonstrate its usefulness over other systems, and finally implement it into the clinic for a clinical trial. The s-DBT system was optimized using different image quality measurements. The optimized system was then used in a breast specimen imaging trial which compared s-DBT to magnified 2D mammography and a conventional single source DBT system. Readers preferred s-DBT to magnified 2D mammography for specimen margin delineation and mass detection, these results were not significant. Using physical measures for spatial resolution the s-DBT system was shown to have improved image quality over conventional single source DBT systems in breast tissue. A separate study showed that s-DBT could be a feasible alternative to FFDM for screening patients with breast implants. Finally, a second s-DBT system was constructed and implemented into the Department of Mammography at UNC hospitals. The first patient was imaged on the system in December of 2013.Doctor of Philosoph

recent developments in cancer nanomedicine

Since decades, conventional diagnosis and treatment strategies for cancer have been practiced widely despite their expensive and time-consuming process. These conventional contrast and therapeutic agents suffer from various side-effects such as low radiodensity and image resolution, rapid clearance, non-specific biodistribution, poor tumor accumulation, high-dose and multiple-dose requirements, nephrotoxicity, uncontrolled exposure of high electromagnetic radiations, whole-body scans, and so on. Therefore, nanosized imaging and therapeutic probes have been proposed recently owing to their promising efficacy and negligible side-effects. However, these nanoplatforms are struggling deeply to find their clinical translational relevance. Integrating targeting ligands with diagnostic and therapeutic agents within a single system at the nanoscale resulted in localized nanotheranostics. Furthermore, the conceptualized nanotheranostics has been recognized as a clinical ‘weapon’ for localized cancer nanomedicine. In this review, we have covered a wide spectrum of recent developments in cancer nanotheranostics. Numerous examples of functional nanohybrids and clinical relevant materials with their multimode imaging and therapeutics have been addressed here. On the other hand, the importance of combination therapies, imaging-guided tumor regression, deep tissue visualization, localized diagnosis and tumor ablation, manipulation of the tumor microenvironment, and so on have been discussed here. Overall, localized and stimuli responsive nanosized multifunctional platforms have proved their superiority over conventional diagnosis and therapies.publishersversionpublishe